BIOMAT Database Logo BIOMAT Database Logo

Effect of hydroxyurea on 2',3'-dideoxycytidine activation. 1994

R P Agarwal, and J He
Department of Medical Oncology (R-71), University of Miami School of Medicine, FL 33101.

The effect of hydroxyurea (HU) on cell growth, cell cycle progression, and the intracellular accumulation of 2',3'-dideoxycytidine (ddC) and ddCTP formation was examined. Twenty-four-hour exposure of H9 cells (human lymphocytic cell line) to 500 microM HU significantly increased the cells in the G1 phase and inhibited cell growth to 33.3 +/- 10.6% of control. The total intracellular ddC and ddCTP accumulation in HU-treated cells increased to 232.3% and 310% of control, respectively.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006918 Hydroxyurea An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. Hydroxycarbamid,Hydrea,Oncocarbide
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D016047 Zalcitabine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy. 2',3'-Dideoxycytidine,Dideoxycytidine,ddC (Antiviral),HIVID Roche,Hivid,NSC-606170,2',3' Dideoxycytidine,NSC 606170,NSC606170

Related Publications

R P Agarwal, and J He
Increased activation of 2',3'-dideoxycytidine by acivicin.
August 1994, Biochemical and biophysical research communications,
R P Agarwal, and J He
Effect of 3'-amino-2',3'-dideoxycytidine on DNA replicative intermediates.
April 1994, Biochemical pharmacology,
R P Agarwal, and J He
Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
January 1993, Drug metabolism and disposition: the biological fate of chemicals,
R P Agarwal, and J He
Effects of 2',3'-dideoxycytidine and 2',3'-dideoxycytidine 5'-triphosphate on phospholipid metabolism in permeabilized rat hepatocytes.
September 1997, Biochemical pharmacology,
R P Agarwal, and J He
Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicity.
January 1992, Laboratory investigation; a journal of technical methods and pathology,
R P Agarwal, and J He
Nucleosides. XI. 2',3'-dideoxycytidine.
March 1967, The Journal of organic chemistry,
R P Agarwal, and J He
Cell line specific radiosensitizing effect of zalcitabine (2',3'-dideoxycytidine).
January 1997, Acta oncologica (Stockholm, Sweden),
R P Agarwal, and J He
Potentiation of 2',3'-dideoxycytidine (ddC) by hydroxyurea and thymidine on the Moloney murine leukemia virus (MoMLV) early replicative steps.
May 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie,
R P Agarwal, and J He
The effect in vitro of 2'-deoxycytidine on the metabolism and cytotoxicity of 2',3'-dideoxycytidine.
May 1990, AIDS (London, England),
R P Agarwal, and J He
Carcinogenicity of 2',3'-dideoxycytidine in mice.
October 1996, Cancer research,
Copied contents to your clipboard!